Apparatus and program for evaluating biological function
09737246 · 2017-08-22
Inventors
Cpc classification
A61B5/14546
HUMAN NECESSITIES
A61B5/7225
HUMAN NECESSITIES
A61B5/743
HUMAN NECESSITIES
A61B5/0205
HUMAN NECESSITIES
A61B5/7278
HUMAN NECESSITIES
International classification
A61B5/1455
HUMAN NECESSITIES
A61B5/0205
HUMAN NECESSITIES
A61B5/145
HUMAN NECESSITIES
Abstract
An apparatus and a program are provided which are capable of simultaneously measuring, evaluating, imaging and displaying the biological function of sites with different biological functions, such as the brain and the muscle, different parts of the brain or different muscle locations, using near-infrared spectroscopy. In an apparatus for evaluating biological function K, physiological indices, including parameters derived from changes in deoxyhemoglobin concentration and changes in oxyhemoglobin concentration, are calculated by a calculating part of a controller. To measure simultaneously, evaluate, image and display the biological functions of sites with different biological function, such as the brain and the muscle, different parts of the brain or different muscle locations, these physiological indices from different sites of the living body are adjusted in such a way that they can be compared with each other by the calculating part and displayed by a display part.
Claims
1. An apparatus for evaluating biological function having a plurality of living body probes for irradiating light to and receiving emitted light from a brain site and a muscle site with different biological functions of a living body, and an apparatus body for entering light information detected by means of said plurality of living body probes and performing calculation, control and memory operations, and utilizing a near-infrared spectroscopy method, wherein said apparatus body comprises: a calculating part for calculating a change in oxyhemoglobin concentration, a change in deoxyhemoglobin concentration, and physiological indices including a variety of parameters derived from the relationships between the change in oxyhemoglobin concentration and the change in deoxyhemoglobin concentration, based on light information from said plurality of living body probes; an adjusting part for adjusting a display form of the physiological indices calculated by means of said calculating part and corresponding to said brain site and said muscle site in such a way that they can be compared as different axes of a graph respectively, wherein the adjusting part adjusts the unit or interval of the scale of the axes at least; and a display part for displaying images based on the information of the physiological indices adjusted by means of said adjusting part.
2. The apparatus for evaluating biological function as claimed in claim 1, wherein said adjusting part adjusts the same physiological indices at the brain site and the muscle site in such a way that they can be compared.
3. The apparatus for evaluating biological function as claimed in claim 1, wherein said adjusting part adjusts different physiological indices at the brain site and the muscle site in such a way that they can be compared.
4. The apparatus for evaluating biological function as claimed in claim 1, wherein said calculating part calculates correlation coefficients of said physiological indices at the brain site and the muscle site, and said display part displays correlation information concerning said correlation coefficients.
5. The apparatus for evaluating biological function as claimed in claim 1, wherein said calculating part multiplies together the same physiological indices at the brain site and the muscle site, and said display part displays product information concerning products of said multiplication.
6. The apparatus for evaluating biological function as claimed in claim 1, wherein said calculating part multiplies together different physiological indices at the brain site and the muscle site, and said display part displays product information concerning products of said multiplication.
7. The apparatus for evaluating biological function as claimed in claim 1, wherein said muscle site includes at least two different muscle sites.
8. The apparatus for evaluating biological function as claimed in claim 1, wherein said brain site includes at least two different brain sites.
9. The apparatus for evaluating biological function as claimed in claim 1, wherein said calculating part calculates change in blood volume concentration (ΔBV) at a region of interest (ROI) by Equation 1:
ΔBV=Δ[Hb]+Δ[HbO.sub.2] (Equation 1) wherein Δ[Hb] is change in deoxyhemoglobin concentration, and Δ[HbO.sub.2] is change in oxyhemoglobin concentration.
10. The apparatus for evaluating biological function as claimed in claim 9, wherein said calculating part calculates a time of maximum muscle blood volume and a time of maximum cerebral blood volume at a desired region of interest (ROI) from a two-dimensional vector diagram showing a relationship between changes in blood volume concentration (ΔBV) at the brain site and the muscle site.
11. The apparatus for evaluating biological function as claimed in claim 1, wherein said calculating part calculates change in oxygen exchange concentration (ΔOE) at a region of interest (ROI) by Equation 2:
ΔOE=Δ[Hb]−Δ[HbO.sub.2] (Equation 2) wherein Δ[Hb] is change in deoxyhemoglobin concentration, and Δ[HbO.sub.2] is change in oxyhemoglobin concentration.
12. The apparatus for evaluating biological function as claimed in claim 11, wherein said calculating part calculates a time of maximum muscle oxygen exchange and a time of maximum cerebral oxygen exchange at a desired region of interest (ROI) from a two-dimensional vector diagram showing a relationship between changes in oxygen exchange concentration (ΔOE) at the brain site and the muscle site.
13. The apparatus for evaluating biological function as claimed in claim 1, wherein said calculating part calculates a ratio e, which is a ratio between change in oxygen exchange concentration (ΔOE) and change in blood volume concentration (ΔBV) at a region of interest (ROI) by Equation 3:
e=ΔOE/ΔBV=(Δ[Hb]−Δ[HbO.sub.2])/(Δ[Hb]+Δ[HbO.sub.2]) (Equation 3) where Δ[Hb] is change in deoxyhemoglobin concentration, and Δ[HbO.sub.2] is change in oxyhemoglobin concentration.
14. The apparatus for evaluating biological function as claimed in claim 13, wherein said calculating part calculates an angle E by Equation 3a:
E=arctan(e) (Equation 3a).
15. The apparatus for evaluating biological function as claimed in claim 14, wherein said calculating part calculates a hybrid angle E (EH), which is an angle formed on a two-dimensional diagram, obtained by taking a first angle E of one of two different sites of said living body as a vertical axis and a second angle E of the other site as a horizontal axis and plotting them over time, between a first angle E [E.sub.1] and a second angle E [E.sub.2], by Equation 3b:
EH=arctan(∠E.sub.1/∠E.sub.2) (Equation 3b).
16. The apparatus for evaluating biological function as claimed in claim 1, wherein said calculating part multiplies the same physiological index at two different sites and calculates a first hybrid angle (H.sub.1), which is an angle formed on a two-dimensional diagram, obtained by taking a first multiplied value of one of the two different sites of said living body as the vertical axis and a second multiplied value from the other site as a horizontal axis and plotting them over time, between the first multiplied value and the second multiplied value, by Equation 3c:
H.sub.1=arctan the first(multiplied value.sub.1/the second multiplied value.sub.2) (Equation 3c).
17. The apparatus for evaluating biological function as claimed in claim 1, wherein said calculating part multiplies different physiological indices at two different sites and calculates a second hybrid angle (H.sub.2), which is an angle formed on a two-dimensional diagram, obtained by taking a third multiplied value of one of the two different sites of said living body as a vertical axis and a fourth multiplied value from the other site as a horizontal axis and plotting them over time, between the third multiplied value and the fourth multiplied value, by Equation 3d:
second hybrid angle H.sub.2=arctan(the third multiplied value.sub.3/the fourth multiplied value.sub.4) (Equation 3d).
18. The apparatus for evaluating biological function as claimed in claim 1, wherein said calculating part calculates a brain/muscle oxygen load ratio (M/B(1)) and a scalar PL.sub.1 (power) during exercise at a plurality of regions of interest (ROIs) of the brain site and the muscle site, from on a two-dimensional diagram and by Equation 4:
M/B(1)=[change in muscle oxygen exchange MOE]/[change in cerebral oxygen exchange COE] (Equation 4).
19. The apparatus for evaluating biological function as claimed in claim 1, wherein said calculating part calculates a brain/muscle blood volume load ratio (M/B(2)) and a scalar PL.sub.2 (power) during exercise at a plurality of regions of interest (ROIs) of the brain site and the muscle site, from on a two-dimensional diagram and by Equation 5:
M/B(2)=[change in muscle blood volume MBV]/[change in cerebral blood volume CBV] (Equation 5).
20. The apparatus for evaluating biological function as claimed in claim 1, wherein said calculating part calculates degree of oxygen saturation Y from a two-dimensional diagram, in which the horizontal axis is an amount of oxyhemoglobin (O) in a region of interest (ROI) and a vertical axis is an amount of deoxyhemoglobin (D) in the ROI, as a slope Y angle on an O/D plane, by Equation 6:
Degree of oxygen saturation Y=1/(1+tan Y angle) (Equation 6).
21. The apparatus for evaluating biological function as claimed in claim 1, wherein said calculating part calculates a ratio E (ratio of oxygen exchange to blood volume), which is defined as a proportion of oxygen exchange (D−O) to total hemoglobin (D+O) at a measurement starting point E.sub.0, from a two-dimensional diagram in which a horizontal axis is an amount of oxyhemoglobin (O) in a region of interest (ROI) and a vertical axis is an amount of deoxyhemoglobin (D) in the ROI, by Equation 7:
E=(D−O)/(D+O) (Equation 7).
22. The apparatus for evaluating biological function as claimed in claim 1, wherein said calculating part calculates change in the degree of oxygen saturation Y (ΔY), from a graph showing a relationship of change in degree of oxygen saturation Y to changes in oxyhemoglobin (ΔO) and changes in deoxyhemoglobin (D), in which a horizontal axis is an amount of oxyhemoglobin (O) in a region of interest (ROI) and a vertical axis is an amount of deoxyhemoglobin (D) in the ROI, by Equation 8:
Change in oxygen saturation ΔY=1/(1+sin.sup.2ΔY angle) (Equation 8).
23. The apparatus for evaluating biological function as claimed in claim 1, wherein said calculating part calculates an arbitrary hypothetical maximum change in the hematocrit (ΔHt.sub.max) with respect to a maximum change in blood volume (ΔBVmax) which is an actual measured value at a region on interest (ROI), by substituting the blood volume at an start of measurement (BV.sub.0) at the ROI into Equation 9:
ΔHt.sub.max=[(ΔO+ΔD).sub.max/(O+D)]=ΔBV.sub.max/BV.sub.0 (Equation 9).
24. The apparatus for evaluating biological function as claimed in claim 23, wherein said ΔBV.sub.max is selected as the maximum change from within a plurality of ROIs.
25. The apparatus for evaluating biological function as claimed in claim 23, wherein an estimated hematocrit value is set for a desired ROI.
26. The apparatus for evaluating biological function as claimed in claim 1, wherein said calculating part calculates an estimated change in degree of oxygen saturation ΔY at a region of interest (ROI) by substituting the blood volume at a start of measurement (BV.sub.0) at the ROI into Equation 10 or Equation 11, and said adjusting part adjusts the graphs showing time series changes in ΔY at the brain site and the muscle site in such a way that they can be displayed by means of said display part,
27. The apparatus for evaluating biological function as claimed in claim 26, wherein said adjusting part adjusts graphs showing time series changes in ΔY at the brain site and the muscle site in such a way that they can be displayed by means of said display part.
28. The apparatus for evaluating biological function as claimed in claim 1, wherein said calculating part calculates ΔL, which is defined by Equation 12, and said adjusting part adjusts said physiological indices from the brain site and the muscle site in such a way that they can be compared and displayed on unit circles of the same size, based on a maximum measured value of ΔL:
(ΔL).sup.2=(Δ[Hb]).sup.2+(Δ[HbO.sub.2]).sup.2 (Equation 12).
29. The apparatus for evaluating biological function as claimed in claim 1, wherein said adjusting part adjusts graphs showing changes in products of multiplication of said physiological indices of the brain site and the muscle site in such a way that they can be displayed on said display part.
30. The apparatus for evaluating biological function as claimed in claim 1, wherein said display part displays graphs showing time series changes, in which a vertical axis is said physiological indices and a horizontal axis is time.
31. The apparatus for evaluating biological function as claimed in claim 1, wherein said display part displays two-dimensional diagrams obtained by taking one of said two different physiological indices as a vertical axis and the other as a horizontal axis and plotting them over time.
32. The apparatus for evaluating biological function as claimed in claim 1, wherein said display part displays images that are color-coded according to a size of values of said physiological indices.
33. The apparatus for evaluating biological function as claimed in claim 1, wherein said display part displays changes in said physiological indices at rest, when there is a task load on said living body, and during recovery, on the same graph.
34. The apparatus for evaluating biological function as claimed in claim 1, wherein said display part displays changes in said physiological indices at rest, when there is a task load on said living body, and during recovery, as a dynamic state as a wave motion and rotational motion of hemoglobin-related parameters on a vector space, and displays the direction and strength of those changes on different graphs and/or image displays.
35. A computer-readable storage device comprising executable instructions that, in response to execution, cause a system comprising a processor to perform operations, comprising: calculating a change in oxyhemoglobin concentration, a change in deoxyhemoglobin concentration, and physiological indices including a variety of parameters derived from the relationships between the change in oxyhemoglobin concentration and the change in deoxyhemoglobin concentration, based on light information from a plurality of living body probes; adjusting a display form of the physiological indices calculated by means of said calculating and corresponding to said brain site and said muscle site in such a way that they can be compared as different axes of a graph respectively, wherein the adjusting adjusts the unit or interval of the scale of the axes at least; and displaying images based on the information of the physiological indices adjusted by means of said adjusting.
Description
BRIEF DESCRIPTION OF THE DRAWINGS
(1)
(2)
(3)
(4)
(5)
(6)
(7)
(8)
(9)
(10)
(11)
(12)
(13)
(14)
(15)
(16)
(17)
(18)
(19)
(20)
(21)
(22)
(23)
(24)
(25)
(26)
(27)
(28)
(29)
(30)
(31)
(32)
(33)
(34)
(35)
(36)
(37)
(38)
(39)
(40)
(41)
(42)
(43)
(44)
(45)
(46)
(47)
(48)
(49)
(50)
(51)
(52)
(53)
(54)
(55)
(56)
(57)
(58)
(59)
(60)
(61)
(62)
(63)
(64)
(65)
(66)
BEST MODE FOR CARRYING OUT THE INVENTION
(67) An embodiment of the present invention is described below with reference to the drawings.
(68) [A Summary of the Apparatus for Evaluating Biological Function]
(69)
(70) The apparatus for evaluating biological function K of the embodiment of the present invention shown in
(71) Each living body probe 1 is composed of at least two light-emitting elements (light-emitting diodes) 1a . . . for irradiating light to the desired measurement site (tissue) of a living body, and at least two light-receiving elements (photodiodes) 1b . . . for receiving light from the measurement site that has been transmitted, reflected, or scattered, etc., after its interaction with the living body.
(72) Living body probes 1 may be placed on and measurements taken from the brain, the muscles of the arm, the muscles of the jaw, the muscles of the fingertips, and the like, but the shape of the living body probes, the surface area measured, how they are placed, and the like, are determined according to the locations where they are placed.
(73) The space between light-emitting probes 1a and light-receiving probes 1b is around 1.5-3 cm when measuring the brain, around 2-3 cm when measuring a muscle of the arm or the jaw, around 5-10 mm when measuring the muscle of the fingertips, and around 2-3.5 mm when measuring the gums in the mouth.
(74) In addition, when living body probes 1 are disposed on a muscle of the arm, if the probes are arranged parallel to the arm, specific muscle oxygen metabolism that accompanies longitudinal extension and contraction of that muscle can be measured. This is because longitudinal extension and contraction of the muscle are reflected in the direction of the longitudinal section of the muscle. If living body probes 1 are placed with the probes arranged perpendicular to the arm, specific muscle oxygen metabolism that accompanies crosswise extension and contraction of that muscle can be measured. This is because changes in the cross-sectional area accompanying flexure and extension are reflected in the cross-section of the muscle.
(75) In addition, an array (in a matrix) of a plurality of living body probes is preferred, in which light-emitting elements 1a and light-receiving elements 1b are spaced at equal intervals. However, for the purpose of identifying brain sites having the most relevance to the muscle exercise selected—that is, identifying from among a plurality of brain measurement sites the locations where the exercise causes the greatest changes (increase/decrease) in oxygen metabolism and the locations where it causes the greatest changes (increase/decrease) in cerebral blood volume, and the sites with the highest correlation—it is not necessary that the distance between light-emitting elements 1a and light-receiving elements 1b be equal; a random arrangement is also possible.
(76) In addition, a two-stage measuring method is possible, in which, once a site with a strong correlation is ascertained, a high-density living body probe array (short distances between light-emitting elements 1a and light-receiving elements 1b) is set up to precisely identify the corresponding site. Namely, it is possible to investigate correlations between muscle and brain and exclude the previously problematic influence of differences in light signal-to-noise ratios at different sites, differences in optical path lengths, and differences in size of the sampling regions sandwiched between living body probes 1.
(77) The apparatus body 2 has a light intensity adjustor 3 for adjusting the intensity of light emitted from light-emitting elements 1a . . . ; a selector-adjustor 4 for selectively activating or deactivating specific light-receiving elements 1b . . . as desired, and for adjusting overall measurement sensitivity; a gain-controllable signal amplifier 5 for amplifying signals from light-receiving elements 1b . . . ; an A/D converter 6 for digitizing the output from signal amplifier 5; a controller 7 for implementing specified mathematical processing based on control processing from various parts of the apparatus and/or output from A/D converter 6; a memory part 8 used for recording output from A/D converter 7, control data from various parts of the apparatus, results of mathematical processing and the like; and a display part 9 for creating displays based on output results from A/D converter 6, results of mathematical processing and the like.
(78) The apparatus body 2 may also have functions for printing various kinds of data and for transmitting and receiving data over a network.
(79) Controller 7 has a calculating part 10 for calculating changes in oxyhemoglobin concentration and changes in deoxyhemoglobin concentration based on light data from the plurality of living body probes 1, and parameters derived from the relationships between them; and an adjusting part 11 for adjusting the amounts of changes and parameters corresponding to the different sites of the living body, calculated by means of calculating part 10, in such a way that they can be compared and displayed on display part 9.
(80) As for the light-emitting probes 1a . . . of the living body probes, two types are provided: those irradiating light with a wavelength of 730 nm, and those irradiating light with a wavelength of 850 nm. (These wavelength numbers are examples; they are not limited to these, and 3 or more wavelengths may also be used in combination.) These may be disposed alternately in a linear direction, but when exploring other patterns, it is important to take into consideration wavelength-dependent attenuation in the tissue and dispose the probes in such away that the received light intensity can be measured in a balanced way. All of light-emitting elements 1a . . . are connected to light adjustor 3 of the apparatus body 2, and the emitted light intensity can be adjusted, either overall or individually.
(81) On the other hand, all the light-receiving elements 1b . . . are connected to signal amplifier 5 through selector-adjustor 4 of the apparatus body; and the received-light signals output from each of light-receiving elements 1b . . . are output, with all or a part of them selectively adjusted by selector-adjustor 4, to signal amplifier 5, where they are amplified. Then, the amplified received-light signals are digitized by A/D converter 6 and output to controller 7.
(82) Controller 7, after applying a low-pass filter to the digital data input from A/D converter 6 to eliminate noise, records this processed data (referred to below as “received light intensity”) chronologically in memory part 8.
(83) In addition, controller 7 executes the operations described below, based on the received light intensity obtained. First, it calculates optical density for wavelength 730 nm (OD.sub.730) by means of Equation 13, and optical density for wavelength 850 nm (OD.sub.850) by means of Equation 14, and at the same time it records the results of these computations chronologically in memory part 8.
OD.sub.730=log.sub.10(I.sub.0 730/I.sub.730) (Equation 13)
OD.sub.850=log.sub.10(I.sub.0 850/I.sub.850) (Equation 14)
(84) where:
(85) I.sub.0 730 is emitted light intensity for wavelength 730 nm
(86) I.sub.730 is received light intensity for wavelength 730 nm
(87) I.sub.0 850 is emitted light intensity for wavelength 850 nm
(88) I.sub.850 is received light intensity for wavelength 850 nm
(89) The relationships between changes in oxyhemoglobin concentration, changes in deoxyhemoglobin concentration, and changes in optical density expressed by Equations 15 and 16 are known to exist from theory known in the art.
ΔOD.sub.730=a.sub.1Δ[HbO.sub.2]+a.sub.1′Δ[Hb] (Equation 15)
ΔOD.sub.850=a.sub.2Δ[HbO.sub.2]+a.sub.2′Δ[Hb] (Equation 16)
(90) where:
(91) ΔOD.sub.730 is change in optical density for wavelength 730 nm
(92) ΔOD.sub.850 is change in optical density for wavelength 850 nm
(93) Δ[HbO.sub.2] is change in oxyhemoglobin concentration
(94) Δ[Hb] is change in deoxyhemoglobin concentration
(95) a.sub.1, a.sub.1′, a.sub.2, a.sub.2′ are optical density coefficients
(96) Equations 17 and 18 can consequently be obtained from these simultaneous equations known in the art.
Δ[HbO.sub.2]=a{ΔOD.sub.730−(a.sub.1′/a.sub.2′)ΔOD.sub.850} (Equation 17)
Δ[Hb]=a(a.sub.2/a.sub.2′)[(a.sub.1/a.sub.2)ΔOD.sub.850−OD.sub.730] (Equation 18)
(97) where:
(98) a=a.sub.2′/(a.sub.1a.sub.2′−a.sub.1′a.sub.2)≈1 (1 or a value approaching 1)
(99) Accordingly, after determining the change in optical density for wavelength 730 nm (ΔOD.sub.730) and the change in optical density for wavelength 850 nm (ΔOD.sub.850), the change in oxyhemoglobin concentration (Δ[HbO.sub.2]) is calculated by means of Equation 17 and the change in deoxyhemoglobin concentration (Δ[Hb]) by means of Equation 18, and the results of these calculations are recorded chronologically in memory part 8. The change in total hemoglobin concentration (Δ[total Hb]) is shown by Equation 19.
Δ[total Hb]=Δ[HbO.sub.2]+Δ[Hb] (Equation 19)
(100) Concentration changes in oxyhemoglobin and deoxyhemoglobin in the capillaries, induced by stimulus to the tissue, can change in the 9 patterns shown below, according to the possible combinations of positive and negative.
(101) (1) ΔHbO.sub.2 increase; ΔHb increase
(102) (2) ΔHbO.sub.2 increase; ΔHb decrease
(103) (3) ΔHbO.sub.2 increase; ΔHb is zero
(104) (4) ΔHbO.sub.2 decrease; ΔHb increase
(105) (5) ΔHbO.sub.2 decrease; ΔHb decrease
(106) (6) ΔHbO.sub.2 decrease; ΔHb is zero
(107) (7) ΔHbO.sub.2 is zero; ΔHb increase
(108) (8) ΔHbO.sub.2 is zero; ΔHb decrease
(109) (9) ΔHbO.sub.2 is zero; ΔHb is zero
(110) In actuality, the above patterns of tissue metabolic activity are changing over time according to differences in such factors as the conditions of stimulus application and the physiological state at rest. Δ[Hb] and Δ[HbO.sub.2] vary in the capillaries as blood flow and metabolic activities for taking up oxygen into the tissues from oxyhemoglobin in the capillaries.
(111) Accordingly, in the present invention, various parameters, derived based on changes in oxyhemoglobin concentration Δ[HbO.sub.2] and changes in deoxyhemoglobin concentration Δ[Hb], are calculated by means of the calculating part 10 of controller 7.
(112) In addition, for the purpose of simultaneously measuring, evaluating, imaging and displaying the biological function of a plurality of sites with different biological functions, such as brain and muscle, different parts of the brain, different muscle locations or the like, adjusting part 11 adjusts the changes in concentration and parameters corresponding to the different sites in the living body and calculated by means of calculating part 10 in such a way that they can be compared and displayed on display part 9.
(113) For example, adjusting part 11 may adjust the units and the size of the increments on the axes of a graph, the size, shape and color of an image, and the like.
(114) Because changes and parameters in, for example, the muscle and the brain are of different magnitudes, if their units and increments and so on are changed, then things like straight line slopes will also change. However, the combination of these positive and negative values, and the direction of trajectories on a two-dimensional diagram (whether they turn right or left), will not change, nor will their phase on a two-dimensional diagram change; and thus it is possible to visualize them as composite indices and observe their dynamics.
(115)
(116) As shown in
(117) Next, based on light information from each of the plurality of living body probes 1, changes in oxyhemoglobin concentration and changes in deoxyhemoglobin concentration and parameters derived from the relationships between them are calculated by means of calculating part 10 of controller 7 (Step S3).
(118) The changes in concentration and parameters corresponding to the different sites of the living body calculated by calculating part 10 are subsequently adjusted in such a way that they can be compared, by means of adjusting part 11 of controller 7 (Step S4), and a variety of graphs and images are displayed on display part 9 (Step S5).
(119) [Display by Means of Graphs Showing Time Series Changes]
(120)
(121)
(122) As can be seen from
(123) Evaluating interrelationships between the brain and the muscle, however, is difficult.
(124) Accordingly, the apparatus K for evaluating biological function of this embodiment of the present invention makes evaluation of interrelationships between different sites possible by using two-dimensional diagrams to compare changes in concentration and parameters corresponding to different sites in the living body.
(125) [Display by Means of Two-Dimensional Diagrams]
(126)
(127) Here, CBV is the abbreviation for cerebral blood volume, and MBV, muscle blood volume.
(128) Here, Δ[Hb] is change in deoxyhemoglobin concentration, and Δ[HbO.sub.2], change in oxyhemoglobin concentration.
(129) Concentration changes in total hemoglobin (Δ[Hb]+Δ[HbO.sub.2]) in the capillaries of the brain, induced by the stimulus of muscle exercise, can change in the 9 patterns shown below, according to the possible combinations of increase and decrease.
(130) TABLE-US-00002 Total hemoglobin in muscle Total hemoglobin in brain Δ[Hb] + Δ[HbO.sub.2] Δ[Hb] + Δ[HbO.sub.2] (1) Increases Increases Quadrant 1 (2) Increases No change(zero) (3) Increases Decreases Quadrant 4 (4) Decreases Increases Quadrant 2 (5) Decreases No change(zero) (6) Decreases Decreases Quadrant 3 (7) No change(zero) Increases (8) No change(zero) No change(zero) (9) No change(zero) Decreases
(131) In
(132)
(133) Units on the vertical and horizontal axes are mmol/l.
(134)
(135) Here, COE is the abbreviation for cerebral oxygen exchange, and MOE, muscle oxygen exchange.
(136) Concentration changes in oxygen consumption (Δ[Hb]−Δ[HbO.sub.2]) in the capillaries of the brain, induced by stimulus in response to muscle exercise, can change in the 9 patterns shown below, according to the possible combinations of increase and decrease.
(137) TABLE-US-00003 Muscle oxygen consumption Brain oxygen consumption Δ[Hb] − Δ[HbO.sub.2] Δ[Hb] − Δ[HbO.sub.2] (1) Increases Increases Quadrant 1 (2) Increases No change(zero) (3) Increases Decreases Quadrant 4 (4) Decreases Increases Quadrant 2 (5) Decreases No change(zero) (6) Decreases Decreases Quadrant 3 (7) No change(zero) Increases (8) No change(zero) No change(zero) (9) No change(zero) Decreases
(138) In
(139)
(140) Units on the vertical and horizontal axes are mmol/l.
(141) As shown in
(142) Here, M/B(1) is defined as:
M/B(1) (muscle-to-brain oxygen load ratio)=change in muscle oxygen exchange (MOE)/change in cerebral oxygen exchange (COE) (Equation 20)
(143)
(144) Units on the vertical and horizontal axes are mmol/l.
(145) As shown in
(146)
(147) Concentration changes in deoxyhemoglobin in the capillaries of the brain can change, induced by stimulus in response to muscle exercise, can change in the 9 patterns shown below, according to the possible combinations of increase and decrease.
(148) TABLE-US-00004 Muscle deoxyhemoglobin Brain deoxyhemoglobin ΔHb ΔHb (1) Increases Increases Quadrant 1 (2) Increases No change(zero) (3) Increases Decreases Quadrant 4 (4) Decreases Increases Quadrant 2 (5) Decreases No change(zero) (6) Decreases Decreases Quadrant 3 (7) No change(zero) Increases (8) No change(zero) No change(zero) (9) No change(zero) Decreases
(149)
(150) The ways in which the concentration changes in oxyhemoglobin in the capillaries of the brain can change, induced by stimulus in response to muscle exercise, show the 9 patterns below, according to the possible combinations of their increase and decrease.
(151) TABLE-US-00005 Muscle oxyhemoglobin Brain oxyhemoglobin ΔHbO.sub.2 ΔHbO.sub.2 (1) Increases Increases Quadrant 1 (2) Increases No change(zero) (3) Increases Decreases Quadrant 4 (4) Decreases Increases Quadrant 2 (5) Decreases No change(zero) (6) Decreases Decreases Quadrant 3 (7) No change(zero) Increases (8) No change(zero) No change(zero) (9) No change(zero) Decreases
(152)
(153) More specifically,
(154)
(155) After the dumbbell load, even though the blood volume is completely recovered (see
(156)
(157)
(158) In
(159) In the post-task recovery period, shown in 14(C), the coordinates can be seen to be in Quadrant 1, in the same way as during the exercise task, shown in
(160)
(161) As
(162)
(163)
(164)
(165)
(166)
(167) In
(168) Variation in the trajectory during the rest period is drawn as a circle, with its maximum distance from the origin as the radius r. It possible to tell from whether a trajectory is inside or outside this circle whether it is from during the rest period or during activity or recovery. Time outside the circle is time of increased activity, and recovery can be judged to be incomplete if the trajectory has not come back into the circle even after the dumbbell exercise.
(169) In actuality, comparing
(170) This shows that the situation of the brain and muscle as regards blood pressure and blood flow have recovered to that at rest; but of the two (brain and muscle), recovery is still incomplete on the brain axis, and even though the dumbbell exercise has stopped, the brain cells are still in a state of excitation.
(171) In addition,
(172)
(173) In this way, by measuring changes in blood volume (D+O) and oxygen exchange (D−O) from the brain and the muscle simultaneously over time during a dumbbell exercise, it is possible, comparing the 2 indices, to evaluate whether the brain is still in the recovery process even after the exercise is stopped. It is possible to see which is likely to recover first, the brain or the muscle; to judge, by watching the trajectories when assigning the next exercise load, whether to start while the recovery is incomplete or after seeing a sufficient recovery, and which recovery time, of the 2 indices, blood volume (D+O) or oxygen exchange (D−O), should be used in starting the next exercise; and thus put together an exercise program.
(174) If a repetition is started when oxygen exchange (D−O) recovery is incomplete, then even with a dumbbell of the same weight, recovery may be delayed and the result may be training with an even stronger load applied to the brain or the muscle. On the other hand, starting after ascertaining recovery from fatigue of the brain and the muscle from the trajectories for blood volume (D+O) and oxygen exchange (D−O) makes it possible to evaluate the length of the recovery period for each exercise. The decision to continue to exercise or not can be made while watching the increasing recovery times as the brain and the muscle gradually become tired.
(175) For example, effectiveness of exercise training can be evaluated by totaling the recovery times for 5 repetitions, or by calculating and displaying each recovery period, and comparing it with that of the next repetition.
(176)
(177) When trajectories for the brain and the muscle are plotted at rest and “normal” is set by determining their maximum radius, then the effectiveness of exercise training can be evaluated, for example, by totaling the recovery times for 5 repetitions, or calculating and displaying each recovery period, and comparing it with that of the next repetition as shown in
(178)
(179) Because recovery after a task may be incomplete, recovery time can also be defined by setting point of recovery as ½ the maximum value of ΔL=r (ΔL/2=r/2), as shown in
(180)
(181) In the two-dimensional diagrams of
(182) From
(183) Namely, if the ratio M/B(1) is constant, then the higher the power value PL.sub.1, the greater the effect of the oxygen load applied to the brain and muscle. It depends on the quadrant, but the closer the ratio M/B(1) or the angle M/B is to zero, the greater the load on the brain.
(184)
(185) In the two-dimensional diagrams of
(186) From
(187) Here, the muscle-to-brain blood volume load ratio (M/B(2)) is defined as:
Muscle-to-brain blood volume load ratio (M/B(2))=[Change in muscle blood volume MBV]/[Change in cerebral blood volume CBV] (Equation 21)
(188) Namely, if the ratio M/B(2) is constant, then the greater the power value PL, the greater the blood volume change—namely, the effect of blood pressure—applied to the brain and muscle.
(189) It depends on the quadrant, but the closer the ratio M/B(2) or the angle M/B is to zero, the greater the load is on the brain.
(190)
(191) The range of the trajectory at rest (maximum values in each quadrant) can be seen in
(192) In
(193) In
(194) In
(195)
(196) The range of the trajectory at rest (maximum values in each quadrant) can be seen in
(197) In
(198) During the task, as shown in
(199) On the other hand, at Channel b, the vector representation shifts into Quadrant 1, and oxygen consumption in the muscle can be seen to level out while oxygen consumption in the brain increases.
(200) In
(201)
(202) The range of the trajectory at rest (maximum values in each quadrant) can be seen in
(203) In
(204) In
(205) Next, techniques for lessening the problem of non-uniform ROIs when taking NIRS measurements from a plurality of sites are described.
(206) Technique 1 for lessening the problem of non-uniform ROIs (regions of interest) when taking NIRS measurements from a plurality of sites
(207) In Technique 1, NIRS signals from the brain, the muscle, and the like can be compared by means of the same quantitative index despite differences in the amounts of change by using a two-dimensional diagram on which ΔD (changes in deoxyhemoglobin) and ΔO (changes in oxyhemoglobin) are plotted; trajectories are drawn on the OD plane, and ΔY is estimated in the capillaries from E=(D−O)/(D+O), the maximum change in blood volume, and the change in the hematocrit (ΔHt=ΔBV/BV.sub.0).
(208) The ratio E (ratio of oxygen exchange to blood volume) is defined as the ratio of oxygen exchange (D−O) to total hemoglobin (D+O).
(209) Measuring changes in oxygen saturation in the capillaries (ΔY), which are unlikely to be affected by the S/N (signal-to-noise ratio) of the ROI, makes it possible to heighten the accuracy of comparisons between sites.
(210)
(211) In
(212) The inventor accordingly investigated this by defining the ratio E for investigating the relationship between changes in total hemoglobin (ΔD+ΔO) and changes in oxygen exchange (ΔD−ΔO). The ratio E (ratio of change in oxygen exchange to change in blood volume) is defined as the ratio of change in oxygen exchange (ΔD−ΔO) to change in total hemoglobin (ΔD+ΔO).
Ratio E=(ΔDΔO)/(ΔD+ΔO)=(k−1)/(k+1) (Equation 22)
where k=ΔD/ΔO
(213) Previously, even with equidistantly spaced emitter and receptor probes, because the distances to the cerebral parenchyma measured from the scalp are not constant, the amounts of hemoglobin (light intensity) from different ROIs (regions of interest) were different
(214) The amounts of oxyhemoglobin (O) and deoxyhemoglobin (D) are [measured] values obtained from a ROI.
K=D/O (Equation 23)
K is the slope on the OD plane shown in
(215) As for the units of the ratio K, it is a ratio of concentrations at a ROI, and even if there are a plurality of ROIs and their sizes are different, it is a parameter that can be compared between them, calculated simultaneously and so on. Of the various NIRS measurement methods, TRS (time-resolved spectroscopy) is used to measure amounts of oxyhemoglobin (O) and deoxyhemoglobin (D) in a ROI.
(216) The blood volume (BV) of a ROI measured by one pair of emitter and receptor probes approximates the amount of total hemoglobin, if the blood serum component is excluded.
(217) It can consequently be expressed as the sum of the amounts of oxyhemoglobin (O) and deoxyhemoglobin (D):
BV=D+O (Equation 24)
(218) As for the difference between the amounts of oxyhemoglobin and deoxyhemoglobin concentrations of a ROI, it can be stated that:
OE=D−O (Equation 25)
(219) Accordingly, the ratio E between the difference and the sum of the concentrations of oxyhemoglobin and deoxyhemoglobin at the ROI is newly defined as:
(220)
(221) As for the units for the ratio E, because, like the ratio K, it is a ratio of concentrations at a ROI, even if there are a plurality of ROIs and their sizes are different, it is a parameter that can be compared between them, calculated simultaneously and so on.
(222) It can be seen from Equations 26 and 23 that E can be expressed as a function of K:
E=(K−1)/(K+1) (Equation 27)
(223) If the degree of oxygen saturation of the ROI is taken to be Y (where 0≦Y≦1), then because
Y=O/(O+D) (Equation 28)
and
1−Y=D/(O+D), (Equation 29)
(224) it follows that from Equations 23, 28, and 29, Y can be expressed as a function of K:
Y=1/(1+K) (Equation 30)
1−Y=K/(1+K), (Equation 31)
(225) and from Equations 26, 28, and 29, E can be expressed as a function of Y:
E=1−2Y (Equation 32)
namely,
Y=(1−E)/2 (Equation 33)
(226) By this means, the degree of oxygen saturation Y is obtained by means of the ratio E between amounts of oxyhemoglobin (O) and deoxyhemoglobin (D), which are obtained by NIRS measurement.
(227) This Y can be regarded as oxygen concentration in the capillaries of a ROI.
(228) This means that a plurality of sets of measurements can be used to obtain a plurality of Y time series, independently of the size of a ROI.
(229) The change in degree of oxygen saturation (ΔY) is determined from the degree of oxygen saturation at the measurement starting point (Y.sub.0) to the degree of oxygen saturation at a point after the measurement starting point (Y.sub.1):
(230) Because E is a linear function of Y, [ΔY] can be determined as follows:
(231)
(232) If the change in degree of oxygen saturation at a ROI is taken to be ΔY (where −1≦ΔY≦1), then there are 4 possibilities for Equation 34: A, B, C or D as described below.
(233) Here,
(234) (A) If ΔBV=0, [ΔY] changes parallel to the D−O axis on the O/D two-dimensional plane:
ΔY=(−1/2)(ΔOE/BV.sub.0) (Equation 10a)
(235) ΔY has the shape of the line ΔOE.
(236) It is calculated from changes in oxyhemoglobin and deoxyhemoglobin obtained from NIRS measurements.
(237) In addition, it can be understood from this equation that ΔOE fluctuates more than ΔBV at rest.
(238) If the ROI at rest=BV.sub.0, then ΔY will appear to be changing, depending on how the probes are placed.
(239)
(240) In the data shown in
(241) When the ratio between standard deviations is 2.0 or more, this means that because there is little Hb at the ROI and not enough light is captured, the site can be judged to have a bad S/N ratio. Namely, uniform ROIs for a plurality of measurement sites can be maintained by setting up the probes in such a way that maintains standard deviation ratios for ΔOE and ΔBV of 2 or less.
(242) In this case, if the change in the degree of oxygen saturation at a ROI is taken to be ΔY (where −1≦ΔY≦1), then:
ΔY=(−1/2)[ΔOE/(BV.sub.0+ΔBV)]+(E.sub.0/2)[ΔBV/(BV.sub.0+ΔBV)]
(243) (B) If ΔOE=0 (ΔD=ΔO), [ΔY] changes parallel to the D+O axis on the O/D two-dimensional plane:
(244)
(245) Namely, ΔY changes by changing parallel to the O+D axis. ΔY is an inverse function of ΔD or ΔO.
(246) Because BV.sub.0 can be thought of as the measurement target ROI, time series changes in ΔY from the measurement starting point will change depending on ΔO or ΔD, as shown in
(247) Namely, the time series changes can be understood by substituting an arbitrary number for BV.sub.0.
(248) (C) If neither ΔBV nor ΔOE is 0 (zero),
(249) ΔY is determined by assigning hypothetical values to O and D during measurement. Namely, time series changes can be understood by substituting an arbitrary number for BV.sub.0.
ΔY=(−1/2)[ΔOE/(BV.sub.0+ΔBV)]+(E.sub.0/2)[ΔBV/(BV.sub.0+ΔBV)]
(250) (D) If ΔY=0, then
E.sub.0=E.sub.1=ΔOE/ΔBV
(251) Here, the relationship between BV.sub.0 and ΔBV in ΔY from Equation 34 is represented by Equation 38:
ΔHt(ΔO+ΔD)/(O+D)=ΔBV/BV.sub.0 (Equation 38)
(252) Ht is the blood volume in the ROI, namely, the hematocrit; and ΔHt represents change in hematocrit. The hematocrit in the arteries and veins is normally from 0.4 to 0.45. In the capillaries, as the ROI becomes smaller, its range changes to from 0.2 to 0.8.
(253) Namely, maximum ΔHb may have a value of from 0.25 to 4.
(254) A method is proposed here whereby, even without knowing the optical path length (PL) by means of the CW (continuous wave) method, time series data for ΔY can be provisionally calculated by the use of a method in which the change in hematocrit ΔHt is provisionally assigned from the maximum value of ΔBV (ΔBV.sub.max) according to Equation 38.
(255) The fact that a response of the brain or muscle, etc., is present when a ROI's hematocrit decreases and ΔBV decreases can be explained from Equation 38.
(256) The following equation is used for estimation:
Maximum ΔHt (ΔHt.sub.max)=(signal intensity of maximum change in ΔBV)/(BV signal intensity in the ROI) (Equation 39)
(257) In this case, the “BV signal intensity in the ROI” can be calculated by substituting an arbitrary number selected from within the range between −1 and 1 for maximum ΔHt in the equation.
(258)
(259) As assumption 1, Y.sub.0=0.7, and E.sub.0=−0.4
(260) As assumption 2, if change in hematocrit is taken to be =−0.25, then the following is obtained from Equation 39:
(BV signal intensity in the ROI)=(signal intensity of maximum change in ΔBV)/(−0.25)
(261) From the above, Equation 35 becomes:
ΔY=−3e/14+0.6/7
e=ΔOE/ΔBV
(262) Y.sub.0 is taken to be: Y.sub.0=0.5 (when degree of oxygen saturation is 50%)
(263) (Degree of oxygen saturation in the capillaries is provisionally estimated to be around 50-60%)
(264) D=0, E.sub.0=0
(265) From Equations 34 and 38, the equation
ΔY=(−1/2)[ΔOE/(BV.sub.0+ΔBV)]+(E.sub.0/2)[ΔBV/(BV.sub.0+ΔBV)]
(266) becomes:
(267)
(268) A method is proposed here whereby, even without knowing the optical path length (PL), time series data for ΔY can be calculated by the use of a model in which the change in hematocrit ΔHt is estimated from the maximum value of ΔBV:
ΔHt=(measured absolute value of maximum ΔBV)/BV
BV=(measured absolute value of maximum ΔBV)/Ht (Equation 41)
(269) In the capillaries, as the ROI becomes smaller, it changes from 0.2 to 0.8; namely, ΔHt may have a value of from around −4 to 4.
(270) Consequently, taking the measurement starting point in Equation 26 as Y.sub.0=0.5, ΔY can be seen to change as a function of e and ΔHt.
(271)
(272) It can be seen from
(273) On the other hand, a hypothetical ΔHt=2 gives ΔY=−1.2, an impossible value.
(274) Namely, this estimation model can also be used to estimate an upper limit to the range of variation of ΔHt.
(275)
(276) It can be seen from
(277) This result suggests that the capillaries are responding to sudden changes in oxygen concentration by changing the number of blood cells.
(278) This shows that a simplified calculation is possible, taking E=0 and Y=0.5.
(279) Namely, Equation 10 becomes the following approximate equation:
(280)
(281)
(282) First, ΔO and ΔD time series data are obtained from measurements from the brain (see
(283) Next, sums and differences are calculated from the ΔO and ΔD time series data (see
(284) These are then inserted in the equation for ΔY, and ΔY is calculated (see
(285) E is calculated from Y at the start of measurement, with an estimated value for ΔHt.
(286) It is influenced by ΔHt, but because the influence of ΔHt on E at the start is small, it can almost always be ignored except for detecting minute changes.
(287) It is clear that ΔY clearly shows different time series data from that of ΔO and ΔD (above), thus providing new information.
(288)
(289)
(290) As can be seen from
(291) It is the primary motor area of the brain that becomes hypoxic while working together with the upper arm biceps, while its surrounding area becomes hyperoxic. Furthermore, during rest, both the primary motor area and its surrounding area are hypoxic, suggesting that the dumbbell exercise load is quite strong.
(292) In the past, even though signal drift occurred during rest, we were unable to explain its physiological meaning. Furthermore, in repetitions 4 and 5, assistance was provided when the subjects became tired and the muscle exercise became difficult to continue, but the hypoxic load continued in the motor area of the brain.
(293) In this way, calculating estimated ΔY makes it possible to measure and evaluate the degree of fatigue in the brain and muscle, the interactions between them, and so on.
(294)
(295)
(296)
(297) In
Oxygen saturation Y=1-arc tan(Y) (Equation 42)
(298) In addition, in
Change in degree of oxygen saturation ΔY=arc tan(∠ΔY) (Equation 43)
(299) This shows that change in the degree of oxygen saturation can occur if there is a change in either change in oxyhemoglobin (ΔO) or change in deoxyhemoglobin (ΔD).
(300) Now, in the past, with fMRI, changes were detected in ΔD, which is paramagnetic, while changes in ΔO, which is diamagnetic, were not detected, and thus changes in oxygen saturation in which ΔD was unchanged were not detected.
(301) In addition, with previous NIRS techniques, not only were ΔD and ΔO handled separately, but change in ΔO was considered the main index, and thus measurements from fMRI and NIRS and the like of changes in degree of oxygen saturation were lacking in accuracy. As
(302) Technique 2 for lessening the problem of non-uniform ROIs (regions of interest) when taking NIRS measurements from a plurality of sites
(303) In Technique 2, a unit circle is drawn on a two-dimensional diagram by means of 2 real time normalizations, using L.
(304) Here, where
(305) D=deoxyhemoglobin,
(306) O=oxyhemoglobin,
(307) ΔD=change in deoxyhemoglobin,
(308) ΔO=changes in oxyhemoglobin,
(309) ΔL is defined by
(310)
(311) If D (deoxyhemoglobin) and O (oxyhemoglobin) can be quantified, then L can be used for normalization instead of ΔL, where L is obtained by:
(312)
(313) First, values for L from the measurement sites are calculated in real time and normalization is performed using the maximum value of L from among the plurality of sites, at intervals of a desired number of seconds.
(314) Or, normalization is performed using the maximum value of L at each site, at intervals of a desired number of seconds.
(315) Then, two-dimensional adjustments (normalizations) are made based on the maximum value of L, normalizing the data at, for example, 5-second intervals, making it possible to evaluate all the data on the same scale, so that it can be seen at a glance where (at which site) changes are occurring, and what percent the changes are of those at the channel showing the maximum value of L, in real time.
(316) For example, the ratio between ΔL.sub.max from the muscle and from the brain is calculated to find the slope on a two-dimensional diagram, with the one N times the other.
Muscle ΔL.sub.max/Brain ΔL.sub.max=N (Equation 46)
(317) In this case, even if the brain and/or the muscle are measured at multiple points, each of their maximum values of L is calculated.
(318)
(319) First, the maximum value of L is selected from a time series of the data (ΔD, ΔO) (see
(320) Next, ΔD+ΔO and ΔD−ΔO are calculated and a time series graph is created (see
(321) Next, a unit circle is created with the maximum value of L as the radius, with ΔD+ΔO as the horizontal axis and ΔD−ΔO as the vertical axis (see
(322) Previously, even if there was a difference between changes from different sites because the ROI sizes (size of the measurement target) were different, it was impossible to tell if small changes were due to differences in size of the ROIs, or to the smallness of the response.
(323) Accordingly, there will be cases of maximum L normalization when the maximum value of L is set for each ROI, and cases when the maximum value of L is selected from among a plurality of ROIs.
(324) Maximum L normalization in which the maximum value of L is set for each ROI is effective in cases when the difference between sites is large, such as the muscle and the brain, or the mouth and the brain.
(325) Selecting the maximum value of L from among a plurality of ROIs is effective when inter-probe spacing is uniform and the ROIs can be quantified, such as in the brain alone, or on the skin alone.
(326)
(327) First, the maximum value of L is selected from a time series of the data (ΔD, ΔO) (see
(328) Next, ΔD+ΔO and ΔD−ΔO are calculated and a time series graph is created (see
(329) Next, a unit circle is created with the maximum value of L as the radius, with ΔD+ΔO as the horizontal axis and ΔD−ΔO as the vertical axis (see
(330) Differences in fluctuation directions, from among the 4 vector directions, and the magnitude of change can be seen from the unit circle normalization.
(331) From the magnitude of that fluctuation, the point when activation occurs due to the task can be seen as a percentage of the whole by superimposing the maximum values for ΔL at rest and the values for ΔL at task completion.
(332) The muscle-to-brain ΔL.sub.max ratio is calculated from the data of
(333)
(334) Maximum values of L (L.sub.max) are calculated from data [sets] A and B, and, for normalization of the data so that L.sub.max=1 (normalization of the amplitude), the inverse of L is calculated and this inverse is taken as the normalization value.
(335) Next, each index (O, D, D−O and D+O) is multiplied by the normalization value, and the normalized data are plotted on a two-dimensional plane (unit circle graph).
(336)
(337) Steps like those described above are also performed when normalizing BV (D+O) and OE (D−O). In this case, however, they not become unit circle graphs.
(338)
(339) It is also possible to perform L.sub.max normalization in real time.
(340) First, a calibration interval is set (for example, 3 s).
(341) Next, after measurement is started, L.sub.max is calculated at 3-s intervals from the measurement start by the same steps described above, and a graph is plotted on a unit circle.
(342) If L.sub.max is not replaced, the graph continues to display in real time with the same normalization value conversion.
(343) If L.sub.max is replaced with a new value, the scale is updated for the data up to that point, and a graph [of the data] after the new normalization value conversion is displayed.
(344)
(345) [Technique 3 for Lessening the Problem of Non-Uniform ROIs (Regions of Interest) when Taking NIRS Measurements from a Plurality of Sites]
(346) Technique 3 is a method which takes the product of data from a plurality of sites.
(347) When measured values from the brain and measured values from the arm are displayed on a two-dimensional diagram, it is necessary to adjust them because the amounts of change and measurement conditions are different.
(348) One way to do this is a time series display of (changes in the brain)×(changes in the arm). This also makes it possible to select out brain sites showing different responses to arm exercise.
(349) When the muscle tires, the brain works harder, but determining the maximum product [of brain and arm data] makes it possible to tell what kind of exercise, when and for how long, and the like, can induce the brain and the muscle to work together effectively. This is an effective way to evaluate training effectiveness.
(350)
(351) From
(352) [Technique 1 for Composite Visualization and Imaging of Physiological Indices]
(353) Here, the present inventor will refer to techniques for composite visualization and imaging of physiological indices (amounts of change and parameters) as “hybrid imaging”. This hybrid imaging includes 2 techniques: Technique 1, in which a physiological index common to a plurality of sites, such as the brain and the muscle, is visualized and imaged in a composite way, and Technique 2, in which a plurality of physiological indices are visualized and imaged in a composite way.
(354)
(355) First, using the apparatus for evaluating physiological function of the embodiment of the present invention, values for physiological indices such as, for example, O (changes in oxyhemoglobin), D (changes in deoxyhemoglobin), OE (changes in oxygen exchange), BV (change in blood volume), the ratio E (ratio of oxygen exchange to blood volume) and the value L (distance within a phase) are determined respectively for the brain and the muscle (Step S11).
(356) Next, a diagram is drawn in 2 dimensions for each physiological index (Step S12).
(357) Next, the slope of the above-mentioned diagram, namely, the correlation coefficient, is calculated for each site by means of calculating part 10 (Step S13).
(358) Next, the correlation coefficient values are displayed on display part 9, color-coded from −1.0 to 1.0 (Step S14).
(359) Next, these are converted to images, divided into before, during and after the task (Step S15). By this means, the relationship between brain metabolism and muscle metabolism during the recovery period can also be seen.
(360) This is hybrid imaging of muscle and brain activity, utilizing the correlation coefficients of physiological indices.
(361)
(362) Thinking of a plurality of hemoglobin indices as trajectories on a vector space and taking into consideration their direction and the magnitude of their strength (scalar) makes it possible to measure the relative strength of muscle and brain activity in real time and convert it to images.
(363) Capturing changes in oxyhemoglobin (ΔO) and changes in deoxyhemoglobin (ΔD) as wave motion and rotational motion dynamics from a measurement starting point on a vector space makes it possible to create a plurality of indices that represent the relationship between the changes in the two: changes in oxyhemoglobin and changes in deoxyhemoglobin.
(364) In
Δ[OE]=Δ[D]−Δ[O]
Δ[BV]=Δ[D]+Δ[O]
Δ[L].sup.2=Δ[D]+Δ[O].sup.2
Ratio E=Δ[OE]/Δ[BV]
Angle E=arc tan (Ratio E)
(365) Using these indices ΔOE, ΔBV, ΔL, Ratio E and Angle E to determine the correlation coefficients between the brain and the muscle, or between sites in the brain, makes it possible to measure and image the relative strengths of muscle and brain activity in real time.
(366)
(367) Here Channel 9 (Ch9) is the primary motor area (M1) of the left brain and Channel 21 (Ch21) is the primary motor area (M1) of the right brain. Channels 6, 7, 8, 10, 11 and 12 surround Channel 9; and Channels 18, 19, 20, 22, 23 and 24 surround Channel 21, in the motor areas surrounding the primary motor areas (M1). Oxygen consumption occurs in the primary motor areas (M1) because it is working, subjected to a load/weight even from muscle exercise, but in the surrounding areas, oxygen is not consumed even though blood is being supplied, and thus they respond differently.
(368)
(369) As can be seen from
(370) In addition, the vector representation shown in
(371)
(372) As can be seen from
(373) In addition, the vector representation shown in
(374) Regarding the equations and R2 in
(375)
(376)
(377) As can be seen from
(378) In addition, according to the vector representation shown in
(379)
(380) In
(381) In
(382) In
(383) In
(384)
(385) In
(386) In
(387) In
(388) In
(389)
(390) In
(391) In
(392) In
(393) In
(394)
(395) In
(396) The images in
(397) Namely, interactions between the indices of a plurality of brain sites and muscle exercise can be evaluated from the relationships between correlation coefficients between the muscle and the brain. This makes it possible to selectively cause oxygen consumption at sites in the brain by adjusting amounts of exercise and exercise times and routines while watching the muscle indices, enabling brain activity and brain training
(398) With previous techniques such as electromyography, the metabolic state of a muscle cannot be evaluated when it is not moving, but with the present invention, simultaneous measurements of the brain and the muscle make it possible to evaluate the state of the brain and the muscle in the recovery process.
(399) In
(400) Because the areas surrounding the primary motor areas show the opposite color, blue at this time, the images can be evaluated to mean that the brain sites outside of M1 show the exact opposite action—not using oxygen—in association with the action of the muscle.
(401) In this way, it can be seen that there is not necessarily one single brain site that supports the movement of the muscle; sites not directly involved also act indirectly in such a way as to smooth the way for brain activity by not using oxygen. This tendency is also seen in the recovery period.
(402) On the other hand, as regards blood volume, all the sites show high blood pressure in almost exactly the same way.
(403) [Two-Dimensional Diagrams of the Brain and the Muscle Using the Angle E]
(404) The angle formed between the angle E of the brain and the angle E of the muscle is defined as the hybrid angle E (EH, or double angle E).
(405)
(406)
(407) By means of EH, which is formed by the ratio between E of the muscle and E of the brain, obtained from the two-dimensional diagram shown in
(408) In
(409) In Quadrant 2, muscle activity is reduced and the brain is working efficiently.
(410) In Quadrant 3, activity is reduced in both the brain and the muscle.
(411) In Quadrant 4, brain activity is reduced and the muscle is working efficiently.
(412)
(413) In addition, Series 1 shows the trajectory for 5 s before a task; Series 2, the trajectory for 36 s during a task (such as lifting a dumbbell); and Series 3, the trajectory for 55 s after the task.
(414) The task here is lifting a 14.5 kg dumbbell.
(415)
(416) It can be seen from
(417)
(418) In addition, the bold line along the horizontal axis shows the time of the task.
(419) It can be seen from
(420) In this way, from the situations on a two-dimensional diagram showing the respective oxygen exchange efficiency of organs or sites, it is possible to read and evaluate the interrelationships between their respective angles EH. From this muscle-to-brain ∠E ratio on a two-dimensional vector diagram, using ∠E from the muscle and brain, interrelationships between the brain and muscle can be classified into 8 sub-quadrants, and evaluated and imaged, quantitatively and over time. In addition, relationships between the working of the muscle and brain become clear, quadrant by quadrant.
(421) In addition, it is possible to make changes in an exercise by viewing the task load from the standpoint of oxygen efficiency and seeing whether it is having enough effect on the brain and the muscle.
(422)
(423) As can be seen from
(424) The fact that there is a high probability that [∠E] is within 90 degrees during the task shows that, because [the area] within 90 degrees indicates high blood volume, pressure in both the brain and the muscle is rising, and the exercise is being done in a state of increased blood volume.
(425) Conversely, it can be said that outside this frame, the load was still such that a response was possible without a regulatory response increasing the blood volume, but with an exercise of lifting the 9 kg dumbbell, the task becomes harder to the point of a regulatory response increasing the blood volume, and the situation is one in which both the muscle and brain are being worked hard.
(426) [Technique 2 for Composite Visualization and Imaging of Physiological Indices]
(427)
(428) First, using the apparatus for evaluating physiological function of the embodiment of the present invention, values for physiological indices such as, for example, O (change in oxyhemoglobin), D (change in deoxyhemoglobin), OE (change in oxygen exchange), BV (change in blood volume), the ratio E (ratio of oxygen exchange to blood volume) and L (distance within a phase), are determined for the brain and the muscle (Step S21).
(429) Next, multiplication by site is performed for each physiological index by means of calculating part 10 (Step S22).
(430) Next, the multiplied values are displayed as time series on display part 9 (Step S23).
(431) Next, the values multiplied by site are displayed on display part 9, color-coded by value (Step S24).
(432) Next, the multiplied values for OE and the multiplied values for BV, for example, are plotted on an OE/BV two-dimensional diagram (Step S25).
(433) This is hybrid imaging of brain and muscle activity, utilizing multiplied values for physiological indices.
(434) Evaluating Two-Dimensional Diagrams Using Products of OE and BV of the Muscle and the Brain
(435) Simultaneous measurement of the muscle and brain makes it possible to show the maximum values for OE products and BV products. The motor region that contributes to moving the right upper arm biceps becomes clear from the OE products.
(436) The angle formed by the OE and BV products is defined as a hybrid angle, by Equation 48, below:
Hybrid angle (∠H)=arc tan {(MOE×COE)/(MBV×CBV)} (Equation 48)
(437) The hybrid angle (∠H angle) represents oxygen exchange efficiency of the brain and muscle working together simultaneously, and an angle of from 0 to 90 degrees shows that they are working efficiently.
(438)
(439)
(440)
(441)
(442) In
(443)
(444) In
(445)
(446) In the figure, “pre-task” shows the trajectory during 5 s before the task, “task” shows the trajectory over 36 s during the task, and “post-task” shows the trajectory during 55 s after the task.
(447) In
(448) In addition, it is possible to see when the most efficient oxygen consumption occurred during the time when the 2 organs are working together (20 s).
(449) [Evaluation Based on Two-Dimensional Diagrams Using Products of OE and BV of the Muscle and the Brain]
(450) Because the load consumed by the brain and muscle [physiological oxygen consumption load (MOE×COE) or blood volume load (MBV×CBV)] represents a synthesis of the energy load from the center and the periphery of the living body, the ability to display and visualize it in real time is significant.
(451) The following results are also clear:
(452) 1) Multiplied OE and multiplied BV do not peak at the same time.
(453) 2) Peaks for OE of the muscle and OE of the brain are not the same.
(454) This evaluation has the following effects:
(455) 1) Timewise, it can be seen that the increase curves of BV and OE at the primary motor areas M1 (Channel 9 in the left brain and Channel 21 in the right brain) do not coincide during the task; the 2 indices are regulated independently (OE increases more rapidly than BV).
(456) 2) By measuring simultaneously, it can be seen, for example, that the increase in OE in the muscle is earlier than that in the brain, and it may act as a trigger for the increase in OE in the brain, and so on.
(457) Imaging based on multiplication makes it possible to evaluate the amount of load (physiological oxygen consumption load) consumed by the brain and muscle.
(458) 3) BV×OE on a brain/muscle two-dimensional plane is a vector cross product; the power output by the brain and muscle is obtained by calculating the area. Using OE(ΔD−ΔO), new evaluations are made possible by multiplying OE loads, synthesizing the center and the periphery by reflecting the OE loads of both the brain and the muscle.
(459)
(460) In
(461) Color-coding in
(462) In
(463) The images in
(464)
(465) In
(466) Color-coding in
(467) In
(468) The images of
(469) As shown in
(470) As shown in
(471) In this case, it can be seen to be 20 s after the start of exercise. Namely, the angle H is an excellent index for quantitatively evaluating and measuring oxygen exchange efficiency when different sites or different organs are working together.
(472) [Program]
(473) Program 12 of the embodiment of the present invention shown in
(474) This Program 12 may also be recorded on a recording media such as a magnetic disk, CD-ROM, semiconductor memory, or the like, and it may also be downloaded over a communications network.
(475) The present invention is not limited to the embodiment described above, and various modifications are possible within the scope of the technical particulars as claimed in the Claims.
(476) For example, the types of physiological indices (amounts of change, parameters), the degree of adjustment of physiological indices by means of adjusting part 11, the combinations of physiological indices to be compared and adjusted, the combinations for correlation coefficients between physiological indices and multiplication of physiological indices, etc., as claimed in the Specification and the Drawings, are illustrative examples, and the present invention is not limited to these.
(477) In addition, a “plurality of sites with different biological functions” refers to sites where the biological function differs to an extent that requires adjustment of their physiological indices by means of adjusting part 11; they are not only the muscle and the brain, but also include different sites in the brain and different muscle sites (for example, arm and leg), etc.
(478) Furthermore, physiological indices for 3 or more sites may also be calculated, adjusted, and displayed on display part 9 by 3-dimensional volumetric images.
INDUSTRIAL APPLICABILITY
(479) The apparatus and program for evaluating biological function of the present invention can be used for simultaneously measuring, evaluating, imaging and displaying the biological function of a plurality of sites with different biological functions, such as the brain and the muscle, different parts of the brain, different muscle locations, and the like.
EXPLANATION OF REFERENCE NUMERALS
(480) K: apparatus for evaluating biological function 1: Living body probe 2: Apparatus body 3: Light intensity adjustor 4: Selector-adjustor 6: A/D converter 7: Controller 8: Memory part 9: Display part 10: Calculating part 11: Adjusting part 12: Program